Issels Integrative Immunotherapy for Cancer or Immuno-Oncology as practiced at the Issels Centers has evolved from the foundation laid by the renowned cancer specialist, Josef M. Issels, M.D. in Germany. He established the world’s first hospital solely dedicated to providing integrative immunotherapy to patients who suffered from advanced and standard therapy-resistant cancer. It eventually expanded to accommodate 120 patient beds.
Vaccines from the patients’ own blood were already being cultured and integrated into the comprehensive immunobiologic core treatment. Issels Integrative Immunotherapy is the treatment of both the cancer tumor and the tumor microenvironment, which plays a pivotal role in cancer progression or regression as latest research confirms.
In view of his expertise and remarkable results, Dr. Josef Issels was invited to serve as an expert member of the German Federal Government Commission in the Fight against Cancer.
John Anderson, M.D., Former Head and Chair of the Department of Medicine at King’s College Hospital Medical School, University of London, England, Former Consultant to the World Health Organization (WHO) on Oncology, visited the Issels Hospital and confirmed the treatment results.
All German insurance companies, including the equivalent of U.S. Medicare, covered treatment at Dr. Issels’ hospital and continue to do so with hospitals offering immunobiologic treatment based on the holistic Issels concept.
The British Broadcasting Corporation (BBC) London aired a 60-minute TV documentary in its prime time show “Tomorrow’s World” featuring Dr. Josef Issels’ exceptional work of immunotherapy for advanced cancer.
Modern research has lately been recognizing the value of immunotherapy, which is now considered the most advanced cancer treatment.